Inceptionr LLC Lowers Stock Position in Amdocs Limited $DOX

Inceptionr LLC cut its stake in shares of Amdocs Limited (NASDAQ:DOX) by 84.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,742 shares of the technology company’s stock after selling 20,249 shares during the quarter. Inceptionr LLC’s holdings in Amdocs were worth $307,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of DOX. Pzena Investment Management LLC increased its holdings in shares of Amdocs by 0.6% in the 3rd quarter. Pzena Investment Management LLC now owns 6,593,249 shares of the technology company’s stock worth $540,976,000 after buying an additional 42,184 shares during the last quarter. LSV Asset Management lifted its holdings in shares of Amdocs by 7.6% during the 3rd quarter. LSV Asset Management now owns 3,648,703 shares of the technology company’s stock worth $299,376,000 after acquiring an additional 257,193 shares during the last quarter. Allspring Global Investments Holdings LLC grew its position in Amdocs by 3.0% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,111,312 shares of the technology company’s stock worth $252,856,000 after acquiring an additional 91,428 shares in the last quarter. Vanguard Group Inc. grew its position in Amdocs by 0.3% in the third quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock worth $251,602,000 after acquiring an additional 9,207 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in Amdocs by 7.4% in the third quarter. Dimensional Fund Advisors LP now owns 2,332,381 shares of the technology company’s stock valued at $191,366,000 after acquiring an additional 160,040 shares during the last quarter. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Stock Performance

NASDAQ DOX opened at $66.92 on Friday. The company has a 50-day simple moving average of $75.35 and a two-hundred day simple moving average of $79.38. Amdocs Limited has a 12-month low of $65.74 and a 12-month high of $95.41. The firm has a market cap of $7.22 billion, a price-to-earnings ratio of 12.94, a PEG ratio of 1.18 and a beta of 0.42. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX) last released its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 EPS for the quarter, topping the consensus estimate of $1.75 by $0.06. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The firm had revenue of $1.16 billion for the quarter, compared to the consensus estimate of $1.15 billion. During the same quarter in the previous year, the business earned $1.66 earnings per share. The company’s quarterly revenue was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. On average, equities analysts forecast that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Tuesday, March 31st will be paid a $0.569 dividend. This is an increase from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.28 dividend on an annualized basis and a yield of 3.4%. Amdocs’s payout ratio is presently 40.81%.

Wall Street Analyst Weigh In

DOX has been the topic of a number of research reports. Barclays lowered their price target on Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 4th. Wolfe Research reiterated a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Stifel Nicolaus decreased their price objective on Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday, February 4th. Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Finally, Wall Street Zen raised Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, Amdocs presently has an average rating of “Moderate Buy” and an average price target of $92.33.

Amdocs Company Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.